Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis
NCT06946550
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to evaluate the effectiveness of a non-ablative 1470 nm laser in treating scarring alopecia in adults. The study will also investigate the biochemical molecular pathways involved in laser therapy by analyzing hair follicle gene expression before and after laser treatment. The main questions it aims to answer are: Does a non-ablative laser work to effectively treat scarring alopecia? What molecular pathways are associated with the laser's effects on hair follicles in scarring alopecia?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Scarring Alopecia
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Montefiore Medical Center
- Last updated on ClinicalTrials.gov
- December 15, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Montefiore Einstein Advanced Care · Elmsford, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.